Brian McNamee - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Executive Vice President - Full Potential Initiatives

Mr. Brian M. McNamee is the Executive Vice President Full Potential Initiatives of Amgen Inc. Mr. McNamee joined the Company in June 2001 as Senior Vice President, Human Resources. From November 1999 to June 2001, Mr. McNamee served as Vice President of Human Resources at Dell Computer Corporationration From 1998 to 1999, Mr. McNamee served as Senior Vice President, Human Resources for the National Broadcasting Corporationrationration, a division of the GE. From July 1988 to November 1999, Mr. McNamee held human resources positions at GE.
Age: 59  President Since 2013      
805 447-1010

Brian McNamee Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Daniel SalvadoriAbbott Laboratories
Michael PariniVertex Pharmaceuticals Incorpor
Michael CrowleyBio Rad Laboratories Inc
Thomas GraneyVertex Pharmaceuticals Incorpor
Georges VosAbbott Laboratories
J WhiteAbbott Laboratories
Paul NavarreAllergan plc
Andrew LaneAbbott Laboratories
Jonathon KellermanAllergan plc
Jared WatkinAbbott Laboratories
Amit SachdevVertex Pharmaceuticals Incorpor
Timothy ErnstBio Rad Laboratories Inc
Matthew MalettaEndo International plc
Paul SilvaVertex Pharmaceuticals Incorpor
Charles FoltzAbbott Laboratories
Michael RousseauAbbott Laboratories
Roger BirdAbbott Laboratories
Shannon HallBio Rad Laboratories Inc
Philippe SchaisonAllergan plc
Antonio PeraEndo International plc
William MeuryAllergan plc

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators